ライフサイエンスコーパス: ICD

1 ICD datalogs were uploaded every approximately 3 months,

2 ICD electrograms preceding the first shock were adjudica

3 ICD episodes were assessed and verified by an independen

4 ICD therapy is an effective therapy in high-risk patient

5 ICD-9-based case definition for suicidal behavior was de

6 ICD-positive patients had more severe depression, poorer

7 ICD-treated VT/VF was associated with NSVT runs at a rat

8 ICDs were interrogated and ambulatory ECGs monitored for

9 ynchronization therapy ICDs, history of >/=1 ICD-treated ventricular tachycardias (VT)/ventricular fi

10 procedures performed in 1,612 hospitals); 2) ICD Registry for implantable cardioverter-defibrillators

11 (ICD-9) code for syphilis and uveitis or (2) ICD-9 code for syphilitic uveitis.

12 t was reached by 25 ablation patients and 26 ICD-only patients.

13 ropriate ICD events, and NICM patients had 7 ICD events.

14 ICD implantation without catheter ablation (ICD-only group: 66+/-8 years; 46 men).

15 eduction in mortality with the ICD (adjusted ICD HR: 0.921; 95% CI: 0.787 to 1.08; p = 0.31), whereas

16 e implant on ambulatory monitoring, 44 after ICD implantation, and 22 on both.

17 ors investigated the long-term outcome after ICD implantation in a large cohort of BrS patients.

18 Although ICD-10 has been adopted in Europe and more recently in t

19 feasibility and safety of AATP in ambulatory ICD patients.

20 An ICD was implanted for secondary prevention in 10 patient

21 The outcome of ADHD was defined as an ICD-coded register diagnosis of ADHD and/or registered p

22 he risk of SCD and obviating the need for an ICD.

23 gly, there is typically no indication for an ICD.

24 41% of SCD cases and 17% of controls had an ICD recommendation (odds ratio, 5.9; P<0.001).

25 A minority of SCD cases had an ICD recommendation according to these guidelines, wherea

26 4% men) and 292 controls, 35% and 14% had an ICD recommendation, respectively (odds ratio, 4.8; P<0.0

27 er and in 500 cases in which patients had an ICD.

28 cond, to evaluate whether implantation of an ICD is associated with a clinical benefit in older patie

29 e risk and hopefully make implantation of an ICD unnecessary.

30 The presence of an ICD was associated with significantly greater proportion

31 Implantation of an ICD with or without CRT.

32 s with EF reassessment, only 11% received an ICD within 1 year.

33 ant reduction in all-cause mortality with an ICD (hazard ratio, 0.75; 95% CI, 0.61-0.93; P = .008; P

34 Adults presented to the ED with an ICD 9/10 code urinary tract infection (UTI) diagnosis du

35 a cohort of 43 patients with PD (12 with an ICD and 31 without) undergoing DBS electrode placement s

36 In our analysis, ICD implantation was associated with improved survival (

37 conditions, 673 had some of the anaphylaxis ICD-10 codes; 309 files (46%) from 209 patients had anap

38 ly defined schizophrenia (ICD-9 code 295 and ICD-10 code F20).

39 Information on mortality (date and ICD-10 code) was ascertained from death certificates.

40 between preimplant ambulatory monitoring and ICD interrogation for detecting NSVT was poor (kappa=0.1

41 tion between reduced all-cause mortality and ICD in patients </=70 years of age (HR, 0.70; 95% CI, 0.

42 pisodes, with associations between NSVT- and ICD-treated ventricular arrhythmias examined.

43 d rates of postdischarge EF reassessment and ICD implantation among 10 289 Medicare-insured patients

44 year freedom from sustained VT/ICD shock and ICD shock, transplant, and death were 58% and 50%, respe

45 CSD decreased sustained VT and ICD shock recurrence in patients with refractory VT.

46 Appropriate ICD therapy can be predicted in ICM patients with primar

47 ICM patients had 27 appropriate ICD events, and NICM patients had 7 ICD events.

48 of follow-up, there were 11 278 appropriate ICD detections of ventricular arrhythmias.

49 arrhythmic events was defined as appropriate ICD therapy or sustained ventricular tachyarrhythmias.

50 atic patients (8.9%) experienced appropriate ICD therapy, all with a spontaneous type 1 electrocardio

51 ive study compares time to first appropriate ICD therapy, time to first inappropriate ICD therapy, ti

52 progressively increased risk of appropriate ICD shocks until >/=98% RVP.

53 ed VAs, sudden cardiac death, or appropriate ICD therapy) in asymptomatic patients with Brugada syndr

54 nd age were also associated with appropriate ICD shocks.

55 /-8 years; 47 men), whereas 57 were assigned ICD implantation without catheter ablation (ICD-only gro

56 f 43 278 patients identified with associated ICD-9 codes of 691.8 or 692.9, 519 and 253 with 691.8 an

57 thy should be considered for ablation before ICD implantation because left ventricular function may i

58 trol disorders/other compulsive behaviours ('ICD behaviours') occur in Parkinson's disease (PD), but

59 a possible age-dependent association between ICD implantation and mortality with survival benefit see

60 e aimed to compare clinical outcomes between ICD patients followed-up in a telemedicine video-confere

61 s a linearly decreasing relationship between ICD and mortality with age (hazard ratio [HR], 1.03; 95%

62 We assessed the relationship between ICD implantation and mortality by age, and an optimal ag

63 Maternal PCOS was defined by ICD-coded register diagnosis.

64 t of new ventricular arrhythmias detected by ICDs in patients without a history of prior ventricular

65 s of ventricular tachycardia, as recorded by ICDs.

66 We show that following CD74 activation, CD74-ICD interacts with the transcription factors RUNX (Runt

67 of its cytosolic intracellular domain (CD74-ICD), which regulates cell survival.

68 terized the transcriptional activity of CD74-ICD in chronic lymphocytic B cells.

69 DS AND Patients with single- or dual-chamber ICDs, engaged in remote monitoring for at least 6 months

70 To compare ICD therapy with conventional care for the primary preve

71 trials, published in any language, comparing ICD therapy with conventional care and reporting mortali

72 Video-conferencing ICD follow-up for patients in areas where electrophysiol

73 anually blind-coded under ICD-10 and current ICD-11 beta draft.

74 ugh the induction of immunogenic cell death (ICD) as well as interfering in the immunosuppressive ind

75 Immunogenic cell death (ICD) is the process by which certain cytotoxic drugs ind

76 evention is implantation of a defibrillator (ICD).

77 h an implantable cardioverter defibrillator (ICD) in patients who are eligible for this therapy in cl

78 ther implantable cardioverter defibrillator (ICD) therapy improves survival for these patients is unk

79 iate implantable cardioverter defibrillator (ICD) therapy in ischemic cardiomyopathy (ICM) and nonisc

80 rsus implantable cardioverter defibrillator (ICD) were compared within the groups of patients treated

81 over implantable cardioverter-defibrillator (ICD) alone.

82 for implantable cardioverter-defibrillator (ICD) candidacy.

83 d by implantable cardioverter-defibrillator (ICD) implantation, but patient stratification remains tr

84 f an implantable cardioverter-defibrillator (ICD) improves survival in patients with cardiomyopathy a

85 Implantable cardioverter-defibrillator (ICD) indications for primary prevention in Brugada syndr

86 The implantable cardioverter-defibrillator (ICD) is the standard therapy to prevent sudden cardiac d

87 , an implantable cardioverter-defibrillator (ICD) is typically required due to an elevated risk for s

88 d to implantable cardioverter-defibrillator (ICD) patients without CRT despite having Class I or IIa

89 Implantable cardioverter-defibrillator (ICD) recipients require close follow-up that can be diff

90 n of implantable cardioverter-defibrillator (ICD) shocks in small series of patients with structural

91 r or implantable cardioverter-defibrillator (ICD) that was "non-MRI-conditional" (i.e., not approved

92 ED), implantable cardioverter-defibrillator (ICD), or wearable cardioverter-defibrillator (WCD).

93 s in implantable cardioverter-defibrillator (ICD)-eligible cardiomyopathy patients.

94 f an implantable cardioverter-defibrillator (ICD).

95 h an implantable cardioverter-defibrillator (ICD).

96 in implantable cardioverter-defibrillators (ICD) decreases patient shock burden but has recognized l

97 ng patients with implantable defibrillators (ICD), use of remote patient monitoring (RPM) is associat

98 of implantable cardioverter defibrillators (ICDs) for primary prevention of sudden cardiac death (pr

99 ith implantable cardioverter defibrillators (ICDs), of whom 94 patients had 24- to 48-hour ambulatory

100 and implantable cardioverter-defibrillators (ICDs) are the mainstay of therapy.

101 of implantable cardioverter-defibrillators (ICDs) for secondary prevention of sudden cardiac death w

102 Implantable cardioverter-defibrillators (ICDs) have a role in preventing cardiac arrest in patien

103 ith implantable cardioverter-defibrillators (ICDs), but ventricular proarrhythmia is less clear.

104 of implantable cardioverter-defibrillators (ICDs), including faster detection rates, reduces unneces

105 ernal shocks, and 1 was rescued by a delayed ICD shock.

106 73719 admissions with the primary diagnosis (ICD-9-CM code) of cellulitis and abscess of finger and t

107 Idiopathic chronic diarrhea (ICD) in rhesus macaques also resembles ulcerative coliti

108 Induced circular dichroism (ICD) of DNA-binding ligands is well known to be strongly

109 wo International Classification of Diseases (ICD) periods, ICD9 (1979-94) and ICD10 (1995-2011).

110 HO International Classification of Diseases (ICD) system to classify diagnoses, health services utili

111 he International Classification of Diseases (ICD)-10.

112 he International Classification of Diseases (ICD)-11 revision timeline, we here propose real-life app

113 (PD) suffer from impulse control disorders (ICDs).

114 g is bidirectional and suggest that the DLL4 ICD could represent a point of cross-talk between Notch

115 Mechanistically, the DLL4 ICD inhibited JUN binding to DNA and thereby controlled

116 We provide evidence that the DLL4 ICD is required for normal DLL4 subcellular localization

117 oteolytically released intracellular domain (ICD) in addition to classical receptor tyrosine kinase-a

118 ed the function of the intracellular domain (ICD) of the Notch ligand Delta-like 4 (DLL4).

119 ligands with swapped intracellular domains (ICDs), demonstrated that the Jagged ICD binds to vimenti

120 sines of the ligands' intracellular domains (ICDs), which sends them into an Epsin-dependent endocyti

121 Special care during ICD implantation, adequate device programming, and regul

122 ies that included data on renal dysfunction, ICD implantation was associated with reduced all-cause m

123 r lysine was functionally required for ErbB4 ICD-mediated inhibition of mammary epithelial cell diffe

124 ry for the SUMOylation, the SUMOylated ErbB4 ICD was tyrosine phosphorylated to a higher extent than

125 Previously, we have demonstrated that ErbB4 ICD is posttranslationally modified by the small ubiquit

126 he conserved lysine residue 714 in the ErbB4 ICD undergoes SUMO modification, which was reversed by s

127 quired for nuclear accumulation of the ErbB4 ICD.

128 ted to a higher extent than unmodified ErbB4 ICD.

129 Ten studies were reviewed that evaluated ICD use in older patients and 4 studies that evaluated u

130 Ten studies were identified that evaluated ICD use in patients with various comorbidities including

131 of 74 patients (8%) without NSVT experienced ICD-treated ventricular tachycardia (VT)/ventricular fib

132 ariable: presence of ICD behaviours and five ICD subtypes assessed by modified Minnesota Impulsive Di

133 dities who would otherwise meet criteria for ICD implantation on the basis of symptoms or left ventri

134 In this study population, an age cutoff for ICD implantation at </=70 years yielded the highest surv

135 An optimal age cutoff for ICD implantation was present at </=70 years.

136 ogy Guidelines specified recommendations for ICD implantation in ACHD patients for the first time.

137 not LGE border zone had predictive value for ICD therapy.

138 ivity conditions' section of the forthcoming ICD-11 can improve the quality of official vital statist

139 r analysis was used to estimate freedom from ICD shock, heart transplantation, and death.

140 reviewed cases in which normally functioning ICDs failed to deliver timely therapy for VF from April

141 co-occurrence of migraine and hypercalcaemia ICD-9 diagnoses (OR = 1.58, P = 4 x 10-13), even after i

142 ructures has been associated with changes in ICD symptoms.

143 competition of paced and intrinsic rhythm in ICD patients.

144 tly predicts ventricular tachyarrhythmias in ICD-eligible cardiomyopathy patients.

145 ate ICD therapy, time to first inappropriate ICD therapy, time to first shock, and overall survival i

146 ine dimer (PBD) or tubulysin payloads induce ICD, modulate the immune microenvironment, and could com

147 domains (ICDs), demonstrated that the Jagged ICD binds to vimentin and contributes to signaling stren

148 programmed parameters and failure of modern ICDs to treat VF.

149 ases, Ninth Revision, Clinical Modification (ICD-9-CM) codes.

150 ases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis code for ulcerative colitis.

151 ases, Ninth Revision, Clinical Modification [ICD-9-CM] code 007.1) from 2006 to 2010, and analyzed cl

152 of real-life application to validate the new ICD-11 'Anaphylaxis' subsection.

153 To analyze the capacity of the new ICD-11 revision to capture anaphylaxis deaths.

154 for binding to RBPJ In the absence of NOTCH ICD, RBPJ recruits L3MBTL3 and the histone demethylase K

155 L3MBTL3 competes with NOTCH ICD for binding to RBPJ In the absence of NOTCH ICD, RBP

156 CSD reduced the burden of ICD shocks from a mean of 18 +/- 30 (median 10) in the y

157 escents aged 12-17 years with a diagnosis of ICD-10 schizophrenia-spectrum disorder, delusional disor

158 the adjusted hazard ratio for the effect of ICD on mortality was 0.64 (95% CI, 0.48-0.85) in patient

159 To examine the efficacy of ICD therapy in reducing risk of all-cause mortality and

160 F was associated with a higher likelihood of ICD implantation for both revascularized (unadjusted, 12

161 t is associated with increased likelihood of ICD implantation, 1-year ICD implantation rates remain v

162 eter ablation did reduce the total number of ICD interventions during the duration of follow-up.

163 Treating clinicians assessed outcomes of ICD diagnosis and functioning (GAF) at 6 months.

164 runs of NSVT were more highly predictive of ICD-treated VT/VF.

165 Surrogate primary variable: presence of ICD behaviours and five ICD subtypes assessed by modifie

166 To assess the presence of ICD behaviours over a 2-year period, and evaluate patien

167 Presence of ICD-10 F10-33 psychotic disorder was confirmed using OPC

168 Point prevalence of ICD behaviours (mMIDI; primary analysis) was stable acro

169 Prevalence of ICD behaviours was relatively stable across the 2-year o

170 eering "Drug hypersensitivity" subsection of ICD-11 and implementation in the WHO International Class

171 We sought to validate the use of ICD-9-CM codes for identifying AD.

172 tudy (Danish Study to Assess the Efficacy of ICDs [Implantable Cardioverter Defibrillators] in Patien

173 tudy (Danish Study to Assess the Efficacy of ICDs in Patients With Non-Ischemic Systolic Heat Failure

174 ssional guidelines that recommend the use of ICDs in such patients.

175 e survival, ancillary treatments, and use of ICDs or WCDs.

176 Critical clinical reasoning when deciding on ICD implantation in ACHD patients, therefore, remains vi

177 One ICD generator could not be interrogated after MRI and re

178 ned 2521 patients to placebo, amiodarone, or ICD between 1997 and 2001.

179 ient with a non-MRI-conditional pacemaker or ICD who underwent clinically indicated nonthoracic MRI a

180 Twenty-one patients (20.2%) had other ICD-related complications (incidence rate 1.4 per 100 pe

181 te risk reduction associated with CRT-D over ICD alone appeared greater than that seen for groups wit

182 ere randomly assigned catheter ablation plus ICD implantation (ablation group: 68+/-8 years; 47 men),

183 M discriminated and calibrated the potential ICD benefit.

184 prophylactic ICD, LGE border zone predicted ICD therapy in univariable and multivariable analysis me

185 cted in ICM patients with primary prevention ICD by quantifying the LGE border zone.

186 ween age and outcome of a primary prevention ICD in patients with nonischemic systolic heart failure

187 We assessed all primary prevention ICD recommendations listed in both documents.

188 y undergoing first-time secondary prevention ICD implantation between 2006 and 2009 in 956 U.S. hospi

189 er patients receiving a secondary prevention ICD survives at least 2 years.

190 Primary prevention ICDs are efficacious at reducing all-cause mortality amo

191 Patients with primary prevention ICDs from the National Cardiovascular Data Registry (NCD

192 data collection started, primary prevention ICDs were hypothesized to reduce all-cause mortality amo

193 tigate the association of primary prevention ICDs with all-cause mortality in patients with nonischem

194 of sudden cardiac death (primary prevention ICDs) in patients with nonischemic cardiomyopathy.

195 e a survival benefit from primary prevention ICDs.

196 ation and patient selection for prophylactic ICD therapy.

197 In ICM patients with primary prophylactic ICD, LGE border zone predicted ICD therapy in univariabl

198 lated cardiomyopathy undergoing prophylactic ICD implantation were prospectively enrolled (age 62+/-1

199 heart failure symptoms, patients who receive ICDs in practice are often older and have more comorbidi

200 ty and mortality of older patients receiving ICDs for secondary prevention in contemporary clinical p

201 cycle lengths were associated with recurrent ICD shocks, whereas advanced New York Heart Association

202 in the National Cardiovascular Data Registry ICD Registry between April 1, 2010, and June 30, 2014.

203 om the National Cardiovascular Data Registry ICD Registry undergoing first-time secondary prevention

204 ctive therapy to treat or prevent repetitive ICD therapies when antiarrhythmic drugs are ineffective

205 ctive therapy to treat or prevent repetitive ICD therapies.

206 al Classification of Diseases-10th Revision (ICD-10) since 2004.

207 al Classification of Diseases-10th Revision (ICD-10).

208 al Classification of Diseases, 9th Revision (ICD-9) code for syphilis and uveitis or (2) ICD-9 code f

209 Classification of Diseases, Ninth Revision (ICD-9), code 136.3, for PCP, or free text documentation

210 Classification of Diseases, Ninth Revision [ICD-9] codes 295, 297 and 298, except 298A and 298B) and

211 and Related Health Problems, Tenth Revision [ICD-10] codes F20 to F29 and International Classificatio

212 peer-reviewed trial for their manufacturer's ICDs.

213 us implantable cardioverter-defibrillator (S-ICD) screening.

214 us implantable cardioverter-defibrillator (S-ICD) was developed to defibrillate ventricular arrhythmi

215 The global EFFORTLESS S-ICD (Evaluation oF FactORs ImpacTing CLinical Outcome an

216 Fifty patients (38%) were ineligible for S-ICD because of screening failure in every lead vector: 3

217 highest risk HCM patients can benefit from S-ICD implantation.

218 at rest and on exercise to inform optimal S-ICD ECG vector development.

219 registry is to determine the safety of the S-ICD by evaluating complications and inappropriate shock

220 This registry demonstrates that the S-ICD fulfills predefined endpoints for safety and efficac

221 Increased R:T wave ratio in the S-ICD screening ECG (odds ratio, 4.0; confidence interval,

222 The S-ICD system and procedure complication rate was 4.1% at 3

223 ical Outcome and Cost EffectiveneSS of the S-ICD) registry is collecting outcomes in 985 patients dur

224 HCM risk factor for sudden death underwent S-ICD ECG screening at rest and on exercise.

225 nd 298B) and narrowly defined schizophrenia (ICD-9 code 295 and ICD-10 code F20).

226 sion occurred if the patient had a secondary ICD-9-CM diagnosis code for Crohn disease or if the pati

227 ity of RPM+ patients was similar to standard ICD RPM patients (hazard ratio, 1.06; 95% confidence int

228 with patients who only transmitted standard ICD RPM data (n=14 183).

229 In patients using standard ICD RPM, the added transmission of weight and blood pres

230 survival benefit with CRT-D versus standard ICD (hazard ration [HR] for death: 0.65; 95% confidence

231 nger than 4 years with CRT-D versus standard ICDs based on a QRSD and morphology were analyzed.

232 andomized clinical trials are needed to test ICD efficacy in patients with an EF >35%.

233 A random effects model demonstrated that ICD use was associated with reduced all-cause mortality

234 d "minimal overlap" analysis also found that ICD use was associated with reduced all-cause mortality

235 The ICD-SPRM interaction was significant (p < 0.0001), such

236 c heart disease, the association between the ICD and survival decreased linearly with increasing age.

237 However, they did not differ from the ICD-negative patients in their severity of PD functional

238 The mean (SD) ages of those in the ICD and CRT-D groups were 67.9 (12.2) years and 68.4 (11

239 cluded 1874 unique patients; 937 were in the ICD group and 937 in the control group.

240 The misclassification of disorders in the ICD system contributes to a lack of ascertainment and re

241 he all-cause mortality rate was lower in the ICD vs placebo group, both in patients whose EF remained

242 erms for anaphylaxis to be included into the ICD-11 framework, WHO has recognized their importance no

243 tes nuclear localization and function of the ICD of ErbB4 receptor tyrosine kinase.

244 clinical trial design and comparison of the ICD with medical therapy (control) in at least 100 patie

245 high agreement regarding sensibility of the ICD-11 usability (Cohen-kappa value 0.75).

246 erior allows contemporaneous delivery of the ICD-inducing chemotherapeutic agent, oxaliplatin (OX).

247 In the outpatient setting, the ICD-9-CM codes 691.8 and 692.9 alone have poor PPV.

248 eriments on an AT-sequence, we show that the ICD of minor-groove-bound 4',6-diamidino-2-phenylindole

249 harge-transfer and the chiral imprint to the ICD demonstrate the inadequacy of a standard Frenkel exc

250 as underlying causes of death utilizing the ICD-11 revision.

251 edian had no reduction in mortality with the ICD (adjusted ICD HR: 0.921; 95% CI: 0.787 to 1.08; p =

252 ly twice the reduction in mortality with the ICD versus SPRM quintile 1 patients (adjusted hazard rat

253 es (52.4%) (Cohen-kappa value 0.63) with the ICD-10 and for 221 codes (71.5%) (Cohen-kappa value 0.77

254 es (71.5%) (Cohen-kappa value 0.77) with the ICD-11.

255 AATP was downloaded into the ICDs of 144 patients (121 men), aged 67.4+/-11.9 years,

256 chamber or cardiac resynchronization therapy ICDs, history of >/=1 ICD-treated ventricular tachycardi

257 e assess the discriminative ability of these ICD recommendations for SCD in ACHD patients.

258 -organic or affective psychosis according to ICD-10 criteria, and were aged between 18 and 65 years w

259 nce ventricular arrhythmias in comparison to ICD (hazard ratio, 0.86; 95% confidence interval, 0.74-0

260 cardiac magnetic resonance imaging prior to ICD implantation were retrospectively included.

261 5% in 186 participants (29.8%) randomized to ICD and 185 participants (28.5%) randomized to placebo.

262 prophylaxis; 884 patients were randomized to ICD and 880 to CRT-D.

263 zed to placebo vs 624 patients randomized to ICD.

264 anaphylaxis were manually blind-coded under ICD-10 and current ICD-11 beta draft.

265 among guideline-eligible patients undergoing ICD placement.

266 with postoperative OD were identified using ICD-9 codes for poisoning from opioids or adverse effect

267 ith a primary diagnosis of burn injury using ICD-9 codes.

268 idity burden and the benefit of CRT-D versus ICD only for death or nonfatal HF events (interaction p

269 CRT-D versus ICD was associated with an improvement in survival in th

270 s with CRT with defibrillator (CRT-D) versus ICD.

271 ric patients (<18 years) were identified via ICD codes for UC and CD in Swedish registers between 199

272 One-year freedom from sustained VT/ICD shock and ICD shock, transplant, and death were 58%

273 dicted the combined endpoint of sustained VT/ICD shock recurrence, death, and transplantation.

274 Patients who were ICD positive at baseline were more likely to be male, yo

275 in accuracy reaching 71.5% of agreement when ICD-11 was used.

276 atients with Brugada syndrome and 2) whether ICD implantation for primary prevention is associated wi

277 process is transparent as advised in the WHO ICD-11 revision agenda, we report the advances and use o

278 28.26% with conventional care to 21.37% with ICD therapy (hazard ratio [HR], 0.81 [95% CI, 0.70 to 0.

279 12.15% with conventional care to 4.39% with ICD therapy (HR, 0.41 [CI, 0.30 to 0.56]), with a simila

280 als with acute diarrhea, and 29 animals with ICD.

281 s and CRESS DNA genomes were associated with ICD relative to healthy animals.

282 re used to analyze variables associated with ICD shock recurrence and mortality after CSD.

283 ring, NSVT was independently associated with ICD-treated ventricular arrhythmias, supporting the impo

284 single run of NSVT were not associated with ICD-treated ventricular arrhythmias.

285 NSVT was significantly associated with ICD-treated VT/VF (adjusted hazard ratio, 3.98; 95% conf

286 itive runs of NSVT were also associated with ICD-treated VT/VF (adjusted hazard ratio, 9.22; 95% conf

287 ses positively or negatively associated with ICD.

288 the clinical benefits of CRT-D compared with ICD alone.

289 esis that in patients with PD diagnosed with ICD, neurons in the STN and GPi would be more responsive

290 n overall effect on all-cause mortality with ICD implantation.

291 similar relative reduction in mortality with ICD therapy as those whose EF remained </=35%.

292 Overall, primary prevention with ICD therapy versus conventional care reduced the inciden

293 Among 98,846 patients with HF (87,914 with ICDs and 10,932 without ICDs), the SHFM was strongly ass

294 ale), 104 patients (28.1%) were treated with ICDs.

295 with HF (87,914 with ICDs and 10,932 without ICDs), the SHFM was strongly associated with all-cause m

296 mortality in a large cohort with and without ICDs, and the SPRM discriminated and calibrated the pote

297 rol patients with heart failure (HF) without ICDs with respect to 5-year survival using multivariable

298 assessment and their association with 1-year ICD implantation in post-MI patients with low EF.

299 eased likelihood of ICD implantation, 1-year ICD implantation rates remain very low even among patien

300 en time-dependent EF reassessment and 1-year ICD implantation, stratified by revascularization status